BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9590329)

  • 1. Protein C in the treatment of coagulopathy in meningococcal disease.
    Rintala E; Seppälä OP; Kotilainen P; Pettilä V; Rasi V
    Crit Care Med; 1998 May; 26(5):965-8. PubMed ID: 9590329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C substitution in sepsis-associated purpura fulminans.
    Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
    Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.
    Smith OP; White B; Vaughan D; Rafferty M; Claffey L; Lyons B; Casey W
    Lancet; 1997 Nov; 350(9091):1590-3. PubMed ID: 9393338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-C concentrate for meningococcal purpura fulminans.
    Cahill M
    Lancet; 1998 Mar; 351(9107):987-8. PubMed ID: 9734969
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein-C concentrate for meningococcal purpura fulminans.
    Kreuz W; Veldman A; Escuriola-Ettingshausen C; Schneider W; Beeg T
    Lancet; 1998 Mar; 351(9107):986-7; author reply 988. PubMed ID: 9734967
    [No Abstract]   [Full Text] [Related]  

  • 7. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
    Vaccarella G; Pelella R
    Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
    Rivard GE; David M; Farrell C; Schwarz HP
    J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C in the treatment of coagulopathy in meningococcal disease.
    Rintala E; Seppälä O; Kotilainen P; Rasi V
    Lancet; 1996 Jun; 347(9017):1767. PubMed ID: 8656927
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal purpura fulminans treated with medicinal leeches.
    Dippenaar R; Smith J; Goussard P; Walters E
    Pediatr Crit Care Med; 2006 Sep; 7(5):476-8. PubMed ID: 16878049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningococcal meningitis in the adult complicated by cutaneous necrosis: description of a clinical case].
    Porro F; Cattaneo M
    Ann Ital Med Int; 2000; 15(4):291-5. PubMed ID: 11202631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial injury in meningococcus-induced purpura fulminans in children.
    Briassoulis G; Narlioglou M; Zavras N; Hatzis T
    Intensive Care Med; 2001 Jun; 27(6):1073-82. PubMed ID: 11497141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
    White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
    Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purpura fulminans in pneumococcal sepsis: case report and review.
    Carpenter CT; Kaiser AB
    Scand J Infect Dis; 1997; 29(5):479-83. PubMed ID: 9435036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.
    Fourrier F; Leclerc F; Aidan K; Sadik A; Jourdain M; Tournoys A; Noizet O
    Intensive Care Med; 2003 Jul; 29(7):1081-7. PubMed ID: 12761614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
    Mertens R; Peschgens T; Granzen B; Heimann G
    Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purpura fulminans during meningococcal sepsis treated with Drotrecogin alpha. A clinical case.
    Belloni G; Ramello P; Salcuni MR; Scavone L; Girotto M; Di Bassiano F
    Minerva Anestesiol; 2006 Apr; 72(4):249-54. PubMed ID: 16570037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.